The effectiveness of methylphenidate (MPH), 0.3 and 0.5 mg/kg 2x daily, in the treatment of 31 children, aged 4 to 6 years, with attention-deficit hyperactivity disorder (ADHD) was investigated by a double-blind, placebo-controlled study at the University of Ottawa, Canada
Randomized placebo-controlled trials have reported efficacy of methylphenidate (MPH) for Attention-d...
Emotional dysregulation (ED) is common in attention-deficit/hyperactivity disorder (ADHD). Nonethele...
Attention-deficit/hyperactivity disorder (ADHD) is one of the common psychiatric problems in childho...
The safety and efficacy of methylphenidate (MPH), 0.3 and 0.6 mg/kg, in 11 preschool children (aged ...
The therapeutic effectiveness of methylphenidate (MPH) (0.3 mg/kg) in attention-deficit hyperactivit...
Objective: The purpose of this study was to examine the effects of methylphenidate (MPH) on function...
Introduction: Attention deficit hyperactivity disorder (ADHD) is generally treated with pharmacologi...
Background: Children with attention deficit hyperactivity disorder/developmental coordination disord...
Longitudinal information indicates children who present with 'hard-to-manage' or problematic behavio...
Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate are reported...
This study has examined the effect of 3 doses of Methylphenidate (MPH) on the speed of motor and cog...
OBJECTIVE: To determine whether children with attention-deficit hyperactivity disorder (ADHD) and le...
In a randomized, double-blind, placebo-controlled study of 60 children aged 8-12 years with ADHD tre...
Randomized placebo-controlled trials have reported efficacy of methylphenidate (MPH) for Attention-d...
Abstract Attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed neurobehavio...
Randomized placebo-controlled trials have reported efficacy of methylphenidate (MPH) for Attention-d...
Emotional dysregulation (ED) is common in attention-deficit/hyperactivity disorder (ADHD). Nonethele...
Attention-deficit/hyperactivity disorder (ADHD) is one of the common psychiatric problems in childho...
The safety and efficacy of methylphenidate (MPH), 0.3 and 0.6 mg/kg, in 11 preschool children (aged ...
The therapeutic effectiveness of methylphenidate (MPH) (0.3 mg/kg) in attention-deficit hyperactivit...
Objective: The purpose of this study was to examine the effects of methylphenidate (MPH) on function...
Introduction: Attention deficit hyperactivity disorder (ADHD) is generally treated with pharmacologi...
Background: Children with attention deficit hyperactivity disorder/developmental coordination disord...
Longitudinal information indicates children who present with 'hard-to-manage' or problematic behavio...
Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate are reported...
This study has examined the effect of 3 doses of Methylphenidate (MPH) on the speed of motor and cog...
OBJECTIVE: To determine whether children with attention-deficit hyperactivity disorder (ADHD) and le...
In a randomized, double-blind, placebo-controlled study of 60 children aged 8-12 years with ADHD tre...
Randomized placebo-controlled trials have reported efficacy of methylphenidate (MPH) for Attention-d...
Abstract Attention deficit hyperactivity disorder (ADHD) is the most commonly diagnosed neurobehavio...
Randomized placebo-controlled trials have reported efficacy of methylphenidate (MPH) for Attention-d...
Emotional dysregulation (ED) is common in attention-deficit/hyperactivity disorder (ADHD). Nonethele...
Attention-deficit/hyperactivity disorder (ADHD) is one of the common psychiatric problems in childho...
DOI
Add to ORKG